Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Cyclosporine may improve low blood counts caused by hematologic cancer.
PURPOSE: Phase II trial to study the effectiveness of cyclosporine in treating patients who
have low blood counts caused by hematologic cancer.